
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
mucolipin 1 CRISPR/Cas9 KO Plasmid (m) | sc-430117 | 20 µg | $397.00 |
Mcoln1 encodes mucolipin 1 (TRPML1), an endolysosomal Ca2+-permeable cation channel that regulates lysosome biogenesis, membrane trafficking, and autophagic flux. TRPML1-mediated Ca2+ release supports lysosome–autophagosome fusion, endocytic cargo processing, and signaling pathways linked to nutrient sensing and cellular stress responses. Disruption of mucolipin 1 function perturbs lysosomal homeostasis, promoting accumulation of undegraded substrates and altered mitochondrial quality control. Mcoln1 is therefore widely studied in models of lysosomal storage disorders and neurodegeneration-associated defects in endolysosomal function.
mucolipin 1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Mcoln1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Mcoln1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Mcoln1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish mucolipin 1 protein expression.
This CRISPR knockout system enables efficient generation of Mcoln1-deficient cell models for investigation of mucolipin 1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.